MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,765.36
-0.47%
NASDAQ 100
$30,725.81
-1.39%
DOW JONES
$51,232.00
+0.10%
NASDAQ Composite
$27,193.34
-1.25%
RUSSELL 2000
$2,775.70
-0.05%
CBOE VIX
$15.41
+2.19%
Sector Heatmap
Technology-1.79%
Financials+0.89%
Healthcare-0.39%
Consumer Cycl+0.31%
Consumer Staples+2.11%
Energy+2.97%
Industrials+0.33%
Materials+0.59%
Real Estate+0.69%
Utilities-0.19%
Comm Services+0.73%
RNAC — Cartesian Therapeutics, Inc. Common Stock
NasdaqCartesian Therapeutics, Inc. Common Stock
$6.82
+0.14(+2.10%)
- O
- 6.68
- H
- 6.82
- L
- 6.50
- V
- 161.74K
⏱️ End-of-day dataAs of Oct 8, 2026
Chart
About RNAC
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateJun 22, 2016
Employees75
Stock ExchangeNasdaq
Ticker SymbolRNAC
Key Financial Statistics
| Market Cap | $222.68M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $5.60 - $11.00 |
| 52-Week Avg Volume | 193.6K |
| VWAP | $6.75 |
| Transactions | 1,950 |
| Total Recorded Bars | 2,589 days |